Chronic HDV is considered the most severe form of viral hepatitis. ・Bulevirtide 2 mg is also approved for use in the European Economic Area (EEA). ・Gilead Sciences concluded the acquisition of Germany ...

Vir Biotechnology recently announced it will present data from its Phase 2 SOLSTICE trial of the tobevibart-elebsiran combination for chronic hepatitis delta at the EASL Congress 2026 in Barcelona, ...

Gilead Sciences received accelerated approval for a chronic hepatitis delta virus treatment from the Food and Drug Administration. The FDA said the Hepcludex treatment, known also as bulevirtide-gmod, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated ...

The Schwab U.S. Dividend Equity ETF (SCHD) and the iShares Core High Dividend ETF (HDV) are two of the best high-yield equity products out there.

Food and Drug Administration ‌said on Friday it ‌approved Gilead Sciences' drug for a ​rare and deadly liver infection that ...

Dividend growth and high yield equity strategies can produce very different results. VIG and HDV are some of the better ...

Not all high-yield ETFs are built the same. In the case of the two major high-dividend yield funds from iShares and Vanguard, ...

HDV charges a marginally higher expense ratio than SCHD but has outperformed over the past year. SCHD offers a higher dividend yield and greater diversification across its 101 holdings. Both funds ...

Tech stocks in a dividend ETF might sound tempting -- but think carefully about your strategy and risk tolerance.